Abstract
The most common cause of erectile dysfunction (ED) is vascular endothelial dysfunction [1]. Cardiovascular diseases share the same risk factors as ED — smoking, hyperlipidaemia, diabetes and hypertension — and the coexistence of a cardiac problem may cause concern with regard to advising on the treatment of ED (Fig. 1). This concern has increased with the realisation that ED is a marker for previously undetected coronary artery disease and the casual use of sildenafil without proper assessment — so-called ‘Internet sex’ — precipitating acute cardiac events [2, 3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Solomon H, Man JW, Jackson G (2003) Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 89: 251–253
Kirby M, Jackson G, Betteridge J, Friedli K (2001) Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 55: 614–618
Solomon H, Man J, Jackson G (2002) Viagra on the Internet — Unsafe Sexual Practice. Int J Clin Pract 56: 403–404
Yusuf S (2002) Two decades of progress in preventing vascular disease. Lancet 360: 2–3
Gillies HC, Roblin D, Jackson G (2002) Coronary and systemic haemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease. Int J Cardiol 86: 131–141
Jackson G, Betteridge J, Dean J, Eardley I, Hall R, Holdright D, Holmes S, Kirby M, Riley A, Sever P (2002) A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement — update 2002. Int J Clin Pract 56: 663–671
Kloner RA, Hutter AM, Emmick JT, Mitchell MI, Denne J, Jackson G (2003) Time course of interaction between tadalafil and nitrates. J Am Coll Cardiol 42: 1855–1860
Webb DJ, Freestone S, Allen MJ, Muirhead GJ (1999) Sildenafil citrate and blood pressure lowering drugs: results of drug interaction studies with an organic nitrate and calcium antagonist. Am J Cardiol 83: 21C–28C
Webb DJ, Muirhead GJ, Wulff M, Sutton JA, Levi R, Dinsmore WW (2000) Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 36: 25–31
Stief C, Porst H, Saenz De Tejada I, Ulbrich E, Beneke M; Vardenafil Study Group (2004) Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. Int J Clin Pract 58: 230–239
Jackson G, Cooper A, McGing E, Martin E (2003) Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in cardiac patients with erectile dysfunction. Int J Imp Res 15 (Suppl 6): 520 (Abst)
Martin E, Cooper A, McGing E, Jackson G (2003) Carrying short acting nitrates is not a contraindication to PDE5 inhibition. Int J Imp Res 15 (Suppl 6): 520 (Abst)
Jackson G, Bedding A, Emmich J (2003) Interaction between tadalafil and two alpha blockers: doxazosin and tamsulosin. Int J Imp Res 15 (Suppl 6): 560 (Abst)
Kloner RA (2004) Cardiovascular Safety of Phosphodiesterase-5 Inhibitors. In: RA Kloner (ed): Heart Disease and Erectile Dysfunction. Humana Press, New Jersey, 139–161
Jackson G (2002) Phosphodiesterase type 5 inhibition in cardiovascular disease: experimental models and potential clinical applications. Eur Heart J 4, Supplements (Suppl H): H19–H23
Langtry HD, Markham A (1999) Sildenafil: A review of its use in erectile dysfunction. Drugs 57: 967–989
Jackson G (2003) PDE5 inhibitors: looking beyond erectile dysfunction. Int J Clin Pract 57: 159–160
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Basel AG
About this chapter
Cite this chapter
Jackson, G. (2004). Sildenafil and cardiovascular events — drug interactions. In: Dunzendorfer, U. (eds) Sildenafil. Milestones in Drug Therapy MDT. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7945-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7945-3_10
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9631-3
Online ISBN: 978-3-0348-7945-3
eBook Packages: Springer Book Archive